Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

886 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability.
Pisani I, Melita G, de Souza PB, Galimberti S, Savino AM, Sarno J, Landoni B, Crippa S, Gotti E, Cuofano C, Pedrini O, Capelli C, Matera G, Belotti D, Cesana S, Cabiati B, Quaroni M, Colombo V, Mazza M, Vergani B, Gaimari A, Nicolini F, Tazzari M, Bocchini M, Serafini M, Rambaldi A, Rambaldi B, Dastoli G, Biondi A, Gaipa G, Introna M, Golay J, Tettamanti S. Pisani I, et al. Among authors: mazza m. J Transl Med. 2025 May 19;23(1):559. doi: 10.1186/s12967-025-06416-3. J Transl Med. 2025. PMID: 40390044 Free PMC article.
CAR T cells targeting options in the fight against multiple myeloma.
Nicolini F, Bravaccini S, Mazza M, Gruszka AM, Tazzari M, MartÍn-Antonio B, Juan M, Ibrahim T, Maltoni R, Martinelli G, Cerchione C. Nicolini F, et al. Among authors: mazza m. Panminerva Med. 2021 Mar;63(1):37-45. doi: 10.23736/S0031-0808.20.04146-4. Epub 2020 Sep 21. Panminerva Med. 2021. PMID: 32955187 Free article. Review.
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.
Martino M, Naso V, Loteta B, Canale FA, Pugliese M, Alati C, Musuraca G, Nappi D, Gaimari A, Nicolini F, Mazza M, Bravaccini S, Derudas D, Martinelli G, Cerchione C. Martino M, et al. Among authors: mazza m. Int J Mol Sci. 2022 Nov 1;23(21):13332. doi: 10.3390/ijms232113332. Int J Mol Sci. 2022. PMID: 36362130 Free PMC article. Review.
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design.
Gaimari A, De Lucia A, Nicolini F, Mazzotti L, Maltoni R, Rughi G, Zurlo M, Marchesini M, Juan M, Parras D, Cerchione C, Martinelli G, Bravaccini S, Tettamanti S, Pasetto A, Pasini L, Magnoni C, Gazzola L, Borges de Souza P, Mazza M. Gaimari A, et al. Among authors: mazza m. Int J Mol Sci. 2024 Nov 13;25(22):12201. doi: 10.3390/ijms252212201. Int J Mol Sci. 2024. PMID: 39596267 Free PMC article. Review.
Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting.
Nicolini F, Bocchini M, Angeli D, Bronte G, Delmonte A, Crinò L, Mazza M. Nicolini F, et al. Among authors: mazza m. Cancers (Basel). 2020 Apr 8;12(4):915. doi: 10.3390/cancers12040915. Cancers (Basel). 2020. PMID: 32276524 Free PMC article. Review.
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia.
Tettamanti S, Rotiroti MC, Giordano Attianese GMP, Arcangeli S, Zhang R, Banerjee P, Galletti G, McManus S, Mazza M, Nicolini F, Martinelli G, Ivan C, Veliz Rodriguez T, Barbaglio F, Scarfò L, Ponzoni M, Wierda W, Gandhi V, Keating M, Biondi A, Caligaris-Cappio F, Biagi E, Ghia P, Bertilaccio MTS. Tettamanti S, et al. Among authors: mazza m. Leuk Lymphoma. 2022 Jul;63(7):1566-1579. doi: 10.1080/10428194.2022.2043299. Epub 2022 Mar 8. Leuk Lymphoma. 2022. PMID: 35259043 Free PMC article.
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy.
De Lucia A, Mazzotti L, Gaimari A, Zurlo M, Maltoni R, Cerchione C, Bravaccini S, Delmonte A, Crinò L, Borges de Souza P, Pasini L, Nicolini F, Bianchi F, Juan M, Calderon H, Magnoni C, Gazzola L, Ulivi P, Mazza M. De Lucia A, et al. Among authors: mazza m. Front Immunol. 2025 Feb 10;16:1515748. doi: 10.3389/fimmu.2025.1515748. eCollection 2025. Front Immunol. 2025. PMID: 39995659 Free PMC article. Review.
Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors.
Bocchini M, Tazzari M, Ravaioli S, Piccinini F, Foca F, Tebaldi M, Nicolini F, Grassi I, Severi S, Calogero RA, Arigoni M, Schrader J, Mazza M, Paganelli G. Bocchini M, et al. Among authors: mazza m. Front Oncol. 2023 May 23;13:1136331. doi: 10.3389/fonc.2023.1136331. eCollection 2023. Front Oncol. 2023. PMID: 37287922 Free PMC article.
886 results